Search

Search Results
Results 161 - 170 of 968 for allergy
  • Dapa-Tabs
    Drug - 11 May 2022
    Consumer Medicine Information (CMI) about Dapa-Tabs (indapamide hemihydrate) intended for persons living in Australia.
  • Zanidip
    Drug - 13 Mar 2022
    Consumer Medicine Information (CMI) about Zanidip intended for persons living in Australia.
  • Lecteva
    Drug - 15 Oct 2020
    Consumer Medicine Information (CMI) about Lecteva (levodopa/carbidopa/entacapone) intended for persons living in Australia.
  • Riamet
    Drug - 22 Jul 2020
    Consumer Medicine Information (CMI) about Riamet (Artemether and lumefantrine) intended for persons living in Australia.
  • Riamet Dispersible Tablets
    Drug - 22 Jul 2020
    Consumer Medicine Information (CMI) about Riamet Dispersible Tablets (artemether and lumefantrine) intended for persons living in Australia.
  • Atrovent UDV
    Drug - 13 Nov 2019
    Consumer Medicine Information (CMI) about Atrovent UDV (ipratropium bromide monohydrate) intended for persons living in Australia.
  • Atrovent Inhalation Solution
    Drug - 12 Nov 2019
    Consumer Medicine Information (CMI) about Atrovent Inhalation Solution (ipratropium bromide monohydrate) intended for persons living in Australia.
  • Minirin Nasal Spray
    Drug - 3 Sep 2019
    Consumer Medicine Information (CMI) about Minirin Nasal Spray (desmopressin acetate) intended for persons living in Australia.
  • Ciproxin HC
    Drug - 11 Jul 2019
    Consumer Medicine Information (CMI) about Ciproxin HC (Ciprofloxacin and Hydrocortisone) intended for persons living in Australia.
  • Giotrif
    Drug - 21 Jun 2019
    Consumer Medicine Information (CMI) about Giotrif (afatinib) intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback